Image (C5ece454 9c87 42df A9f9 Fc9806d7c312 01)
Quetiapine Tablet, Extended Release
Product Images NDC 71335-2641
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Quetiapine (NDC 71335-2641). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image (C5ece454 9c87 42df A9f9 Fc9806d7c312 02)
Image (C5ece454 9c87 42df A9f9 Fc9806d7c312 03)
Image (C5ece454 9c87 42df A9f9 Fc9806d7c312 04)
Image (C5ece454 9c87 42df A9f9 Fc9806d7c312 05)
Label (Lbl713352641)
This is a product description for Quetiapine Extended-Release Tablets, USP. Each tablet contains 460.50 mg of Quetiapine Fumarate, equivalent to 400 mg Quetiapine. The usual dosage is once daily. It is recommended to scan the Package Insert QR code for prescribing information. The tablets should be swallowed whole and not split, crushed, or chewed. The product should be stored at 20° to 25°C (68° to 77°F) with excursions permitted to 15° to 30°C (59° to 86°F). A warning to keep the medication out of reach of children is provided. The packaging includes 60 tablets.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
